DK1073462T3 - Kombinationsvaccine mod hepatitis A og hepatitis B - Google Patents

Kombinationsvaccine mod hepatitis A og hepatitis B

Info

Publication number
DK1073462T3
DK1073462T3 DK99924871T DK99924871T DK1073462T3 DK 1073462 T3 DK1073462 T3 DK 1073462T3 DK 99924871 T DK99924871 T DK 99924871T DK 99924871 T DK99924871 T DK 99924871T DK 1073462 T3 DK1073462 T3 DK 1073462T3
Authority
DK
Denmark
Prior art keywords
hepatitis
vaccine against
combination vaccine
against hepatitis
combination
Prior art date
Application number
DK99924871T
Other languages
English (en)
Inventor
Claude Artois
Michael J Clark
Clothilde Thiriart
Stefan Gabriel Jozef Thoelen
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of DK1073462T3 publication Critical patent/DK1073462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99924871T 1998-05-01 1999-04-27 Kombinationsvaccine mod hepatitis A og hepatitis B DK1073462T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition
PCT/EP1999/003024 WO1999056772A2 (en) 1998-05-01 1999-04-27 Hepatitis vaccine

Publications (1)

Publication Number Publication Date
DK1073462T3 true DK1073462T3 (da) 2007-02-26

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99924871T DK1073462T3 (da) 1998-05-01 1999-04-27 Kombinationsvaccine mod hepatitis A og hepatitis B

Country Status (28)

Country Link
EP (1) EP1073462B1 (da)
JP (2) JP5138843B2 (da)
KR (1) KR100612547B1 (da)
CN (1) CN1263509C (da)
AR (1) AR016987A1 (da)
AT (1) ATE345815T1 (da)
AU (1) AU743759B2 (da)
BR (1) BR9910157A (da)
CA (1) CA2331086C (da)
CO (1) CO5050367A1 (da)
CY (1) CY1107322T1 (da)
CZ (1) CZ301232B6 (da)
DE (1) DE69934108T2 (da)
DK (1) DK1073462T3 (da)
ES (1) ES2277437T3 (da)
GB (1) GB9809507D0 (da)
GC (1) GC0000101A (da)
HU (1) HU228209B1 (da)
IL (1) IL139269A0 (da)
MY (1) MY128929A (da)
NO (1) NO20005483L (da)
NZ (1) NZ507902A (da)
PL (1) PL190729B1 (da)
PT (1) PT1073462E (da)
TR (1) TR200003235T2 (da)
TW (1) TW553744B (da)
WO (1) WO1999056772A2 (da)
ZA (1) ZA200006118B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
JP2022513001A (ja) * 2018-11-13 2022-02-07 ヴァリエーション バイオテクノロジーズ インコーポレイテッド Ｂ型肝炎の治療のための免疫原性組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
DE69319728T2 (de) * 1992-05-23 1999-02-04 Smithkline Beecham Biologicals S.A., Rixensart Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
WO1997035612A1 (fr) * 1996-03-23 1997-10-02 The Research Foundation For Microbial Diseases Of Osaka University Antigene a fragment fonctionnel de la toxine du tetanos, et vaccin contre le tetanos

Also Published As

Publication number Publication date
HUP0101652A3 (en) 2004-10-28
PL190729B1 (pl) 2005-12-30
ATE345815T1 (de) 2006-12-15
CO5050367A1 (es) 2001-06-27
CA2331086A1 (en) 1999-11-11
EP1073462B1 (en) 2006-11-22
TW553744B (en) 2003-09-21
PT1073462E (pt) 2007-01-31
KR20010043224A (ko) 2001-05-25
NO20005483D0 (no) 2000-10-31
NO20005483L (no) 2000-12-08
CZ20004061A3 (cs) 2001-04-11
AU4137999A (en) 1999-11-23
BR9910157A (pt) 2001-01-09
CY1107322T1 (el) 2012-11-21
WO1999056772A3 (en) 2000-02-03
HK1034202A1 (en) 2001-10-19
GB9809507D0 (en) 1998-07-01
AR016987A1 (es) 2001-08-01
JP2010209118A (ja) 2010-09-24
JP5138843B2 (ja) 2013-02-06
NZ507902A (en) 2002-03-28
PL344137A1 (en) 2001-10-08
AU743759B2 (en) 2002-02-07
KR100612547B1 (ko) 2006-08-11
GC0000101A (en) 2005-06-29
WO1999056772A2 (en) 1999-11-11
HUP0101652A1 (hu) 2001-09-28
CN1308547A (zh) 2001-08-15
CZ301232B6 (cs) 2009-12-16
HU228209B1 (en) 2013-01-28
CN1263509C (zh) 2006-07-12
ZA200006118B (en) 2002-01-30
ES2277437T3 (es) 2007-07-01
TR200003235T2 (tr) 2001-03-21
MY128929A (en) 2007-02-28
IL139269A0 (en) 2001-11-25
CA2331086C (en) 2010-06-22
DE69934108T2 (de) 2007-04-19
JP2002513771A (ja) 2002-05-14
DE69934108D1 (de) 2007-01-04
EP1073462A2 (en) 2001-02-07

Similar Documents

Publication Publication Date Title
DK1210112T3 (da) Vaccine mod HBV og HPV
NO20032753L (no) Forbindelse og anvendelse derav
DK1410805T3 (da) Vaccine mod HPV
DE69932709D1 (de) Hib/dtpa impfstoff und herstellungsmethoden
NO20003302L (no) Vaksine
NO20004544D0 (no) Forbedret pumpeanordning og forbedrede fremgangsmÕter
ATE209045T1 (de) Hepatitis b impfstoff
EP1083926A4 (en) VACCINE
NO995811L (no) Selvgjenopprettende og selvbekreftende kryptosystemer
DK1068238T3 (da) Integrinheterodimer og subunit deraf
PT955810E (pt) Misturas solidas a base de sulfonilureias e adjuvantes
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
NO20001958L (no) Synergistiske sammensetninger omfattende et oksatiazin og et benzotiofen-2-karboksamid-S,S-dioksid
NO20005599L (no) Vaksine
NO20005502D0 (no) Polymerer og deres anvendelse
ATE345815T1 (de) Kombinierte impfstoffe gegen hepatitis a und hepatitis b
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
EP1105154A4 (en) BACTERIAL VACCINES WITH SUPERANTIGENES
DE59706259D1 (de) Palatinalsplitschraube
DK1180041T4 (da) Vaccine mod ISA-virus
NO20006456D0 (no) En mutant human hepatitt B viral stamme og anvendelser derav
ATE431415T1 (de) Hiv impfstoff
DK199801305A (da) Legetøjsbyggesæt
DK1341969T3 (da) En stöjabsorberende og/eller -reducerende skærm
ATA208398A (de) Handstück